Kilitch Drugs (India) Ltd. engages in the manufacture and sale of pharmaceuticals, medicinal chemical, and botanical products. The company is headquartered in Mumbai, Maharashtra. The firm is primarily engaged in the development, manufacturing, and marketing of finished dosages. The Company’s products portfolio includes Parenteral and Nasal Products, Oral, Effervescent, Nutritional Products, Medical Devices, and Cosmetics and Herbal Products. Its Parenteral and Nasal Products has a range of products that help in gastroenterology, anti-inflammatory, anti-malaria, diagnostic, uterine stimulants, veterinary and many other areas in the form of ampoules and vials. The Company’s range of oral formulations includes tablets, capsules, dry syrups and oral powders. The Company’s medical devices offer a C-Seal brand. The company has a range of cosmetics ranging from oil, lotion and liquid to cream and paste in skin care, personal care, and hair care category. The firm has its manufacturing units located in India and Ethiopia.
Loading chart…
Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:
The headline call - descriptive label, conviction, and the synthesis behind it.
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Forensic and governance risk pointers, severity-ranked.
Solvency and earnings-quality score.
Quarter-by-quarter earnings-call briefs - what changed and why.